{"Name":"Mateon Therapeutics","perma":"oxigene","BasicInfo":{"funded":"1988-01-01","isClosed":false,"closed":null,"short":"Mateon is a biopharmaceutical company, develops anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases."},"FundingRounds":[{"funding_type":"venture","series":null,"announcedDate":"2010-03-26","moneyRaised":7500000}],"Acquisitions":[{"price":33000000,"paymentType":"cash_and_stock","announcedDate":"2009-10-01","acquireeName":"VaxGen"},{"price":34200000,"paymentType":null,"announcedDate":"2009-07-03","acquireeName":"Symphony Vida"}],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"MATN","shares":null,"date":"1993-09-03","openPrice":null,"moneyRaised":null,"valuation":null},"Investments":[],"Products":[],"CurrentTeam":[{"title":"CEO","started":null,"ended":null,"firstName":"David","lastName":"Chaplin"},{"title":"V P, Legal Affairs","started":"2010-01-01","ended":null,"firstName":"Clint","lastName":"Webb"},{"title":"CFO","started":null,"ended":null,"firstName":"James","lastName":"B. Murphy"},{"title":"CEO","started":null,"ended":null,"firstName":"Richard","lastName":"Chin"}],"PastTeam":[{"title":"Vice President, Regulatory Affairs and Quality Assurance","started":"2011-12-01","ended":"2012-01-01","firstName":"Paula","lastName":"Adams"},{"title":"Senior Director, Regulatory Affairs and Quality Assurance","started":"2009-08-01","ended":"2011-12-01","firstName":"Paula","lastName":"Adams"},{"title":"CFO & CEO","started":"2000-01-01","ended":"2006-01-01","firstName":"Fredrick","lastName":"W. Driscoll"}]}
